Ebola virus infection in host (WP4217)

Homo sapiens

Open in new tab Open in NDEx Open in Newt (SBGN)
Download PNG Download SVG Download JSON Download GPML Learn more about Downloads
The Ebola virus (EBOV) pathway represents the virus infection on humans, depicted from the left to the right of the picture. The initial targets are macrophages and dendritic cells, but the virus has tropism to infect all kinds of cells, with the exception of lymphocytes. Here we represent all cells in general within one diagram. Ebola attaches to the plasma membrane and after that, a viral glycoprotein induces penetration by endocytosis. This process is made by membrane proteins. During the penetration, its particles travel in compartments where viral glycoproteins are cleaved and fused to the endosomal membrane, which results in the uncoating of viral particles into the cell's cytoplasm. The virus then begins replicating and down-regulating the host's immune response. During the release process, the newly-created viruses are released from host cells, either by causing them to break apart, by waiting for their death, or by budding off through their membrane. Depending on the type of infected cell some trans-infection could happen. This pathway was built using a text-mining approach to obtain interactions between genes related to this process. To our knowledge, it is the first comprehensive pathway depicting the Ebola pathway to date.

Authors

Elisson nl , Denise Slenter , Kristina Hanspers , Eric Weitz , Martina Summer-Kutmon , and Egon Willighagen

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Diseases

Annotations

Disease Ontology

viral infectious disease Ebola hemorrhagic fever

Participants
Query Drugst.One

Label Type Compact URI Comment
ITGA2 GeneProduct ensembl:ENSG00000164171
Filamin A GeneProduct ncbigene:2316
CLEC10A GeneProduct ensembl:ENSG00000132514
ASGR1 GeneProduct ensembl:ENSG00000141505
ADAM17 GeneProduct ensembl:ENSG00000151694
ICAM2 GeneProduct ensembl:ENSG00000108622
ICAM3 GeneProduct ensembl:ENSG00000076662
RHOB GeneProduct ensembl:ENSG00000143878
CD209 GeneProduct ensembl:ENSG00000090659
CLEC4M GeneProduct ensembl:ENSG00000104938
HAVCR1 GeneProduct ensembl:ENSG00000113249
GAS6 GeneProduct ensembl:ENSG00000183087
TYRO3 GeneProduct ensembl:ENSG00000092445
ITGA3 GeneProduct ensembl:ENSG00000005884
ITGA4 GeneProduct ensembl:ENSG00000115232
ITGA5 GeneProduct ensembl:ENSG00000161638
ITGA1 GeneProduct ensembl:ENSG00000213949
ITGA6 GeneProduct ensembl:ENSG00000091409
ITGB1 GeneProduct ensembl:ENSG00000150093
ITGB3 GeneProduct ensembl:ENSG00000259207
BST2 GeneProduct ensembl:ENSG00000130303
RAB7A GeneProduct ensembl:ENSG00000075785
RAB5A GeneProduct ensembl:ENSG00000144566
NPC1 GeneProduct ensembl:ENSG00000141458
NPC2 GeneProduct ensembl:ENSG00000119655
CTSB GeneProduct ensembl:ENSG00000164733
CTSL GeneProduct ensembl:ENSG00000135047
AXL GeneProduct ensembl:ENSG00000167601
MERTK GeneProduct ensembl:ENSG00000153208
IKBKE GeneProduct ensembl:ENSG00000263528
IRF7 GeneProduct ensembl:ENSG00000185507
KPNA1 GeneProduct ensembl:ENSG00000114030
CLEC4G GeneProduct ensembl:ENSG00000182566
IQGAP1 GeneProduct ensembl:ENSG00000140575
TBK1 GeneProduct ensembl:ENSG00000183735
C1QBP GeneProduct ensembl:ENSG00000108561
TLR4 GeneProduct ensembl:ENSG00000136869
TIMD4 GeneProduct ensembl:ENSG00000145850
TPCN2 GeneProduct ensembl:ENSG00000162341
TSG101 GeneProduct ensembl:ENSG00000074319
STAT1 GeneProduct ensembl:ENSG00000115415
NEDD4 GeneProduct ensembl:ENSG00000069869
SOCS3 GeneProduct ensembl:ENSG00000184557
PIK3R GeneProduct ensembl:ENSG00000145675
CDC42 GeneProduct ensembl:ENSG00000070831
IRF3 GeneProduct ensembl:ENSG00000126456
CLATHRIN GeneProduct ncbigene:1211
ITGAV GeneProduct ensembl:ENSG00000138448
CLEC6A GeneProduct ensembl:ENSG00000205846
MBL2 GeneProduct ensembl:ENSG00000165471
CAVEOLIN GeneProduct interpro:IPR001612
FOLR1 GeneProduct ensembl:ENSG00000110195
RHOC GeneProduct ensembl:ENSG00000155366
RAC1 GeneProduct ensembl:ENSG00000136238
EGFR GeneProduct ensembl:ENSG00000146648
AKT1 GeneProduct ensembl:ENSG00000142208
MFGE8 GeneProduct ensembl:ENSG00000140545
CD300A GeneProduct ensembl:ENSG00000167851
PRKRA GeneProduct ensembl:ENSG00000180228
DDX58 GeneProduct ensembl:ENSG00000107201
HAVCR2 GeneProduct ensembl:ENSG00000135077
IL4 GeneProduct ensembl:ENSG00000113520
DAB2IP GeneProduct ensembl:ENSG00000136848
TFAP2A GeneProduct ensembl:ENSG00000137203
RAB9A GeneProduct ensembl:ENSG00000123595 PUBMED
EIF2AK2 GeneProduct ensembl:ENSG00000055332
EIF2S1 GeneProduct ensembl:ENSG00000134001
VPS33A GeneProduct ensembl:ENSG00000139719
VPS18 GeneProduct ensembl:ENSG00000104142
VPS39 GeneProduct ensembl:ENSG00000166887
VPS41 GeneProduct ensembl:ENSG00000006715
VPS11 GeneProduct ensembl:ENSG00000160695
VPS16 GeneProduct ensembl:ENSG00000215305
NFKB GeneProduct ensembl:ENSG00000109320
VPS4A GeneProduct ensembl:ENSG00000132612
EPS15 GeneProduct ensembl:ENSG00000085832
RASA2 GeneProduct ensembl:ENSG00000155903
RHOA GeneProduct ensembl:ENSG00000067560
GELSOLIN GeneProduct uniprot:A0A0A0MS51
ACTIN GeneProduct interpro:IPR004000
EP300 GeneProduct ensembl:ENSG00000100393
CREBBP GeneProduct ensembl:ENSG00000005339
CDC44 GeneProduct uniprot:P35251 Annotated according to synonimic name with RFC1 according to Uniprot (although not mentioned for Homo sapiens species).
F-ACTIN GeneProduct ensembl:ENSG00000075624
PAK1 GeneProduct ensembl:ENSG00000149269
TIAM1 GeneProduct ensembl:ENSG00000156299
VAV2 GeneProduct ensembl:ENSG00000160293
IGF1R GeneProduct ensembl:ENSG00000140443
CLTC GeneProduct ensembl:ENSG00000141367
CLTA GeneProduct ensembl:ENSG00000122705
CLTB GeneProduct ensembl:ENSG00000175416
CLTCL1 GeneProduct ensembl:ENSG00000070371
CAV1 GeneProduct ensembl:ENSG00000105974
CAV2 GeneProduct ensembl:ENSG00000105971
CAV3 GeneProduct ensembl:ENSG00000182533
PIK3R1 GeneProduct ensembl:ENSG00000145675
PIK3CA GeneProduct ensembl:ENSG00000121879
PIK3CB GeneProduct ensembl:ENSG00000051382
PIK3CD GeneProduct ensembl:ENSG00000171608
PIK3R3 GeneProduct ensembl:ENSG00000117461
PIK3R2 GeneProduct ensembl:ENSG00000105647
PP1 GeneProduct eccode:3.1.3.16
LC8 GeneProduct ncbiprotein:8655
TOP1 GeneProduct ensembl:ENSG00000198900
FLNA GeneProduct ensembl:ENSG00000196924
FLNB GeneProduct ensembl:ENSG00000136068
FLNC GeneProduct ensembl:ENSG00000128591
GSN GeneProduct ensembl:ENSG00000148180
SCIN GeneProduct ensembl:ENSG00000006747
MAPK1 GeneProduct ensembl:ENSG00000100030
MAPK3 GeneProduct hgnc.symbol:MAPK3
NFKB1 GeneProduct ensembl:ENSG00000109320
NFKB2 GeneProduct ensembl:ENSG00000077150
REL GeneProduct ncbigene:5966
RELA GeneProduct ensembl:ENSG00000173039
ACTN1 GeneProduct ensembl:ENSG00000072110
ACTN4 GeneProduct ensembl:ENSG00000130402
ACTB GeneProduct ensembl:ENSG00000075624
ACTG1 GeneProduct ensembl:ENSG00000184009
HLA-A GeneProduct ensembl:ENSG00000206503
HLA-B GeneProduct ensembl:ENSG00000234745
HLA-C GeneProduct ensembl:ENSG00000204525
HLA-DMA GeneProduct ensembl:ENSG00000204257
HLA-DMB GeneProduct ensembl:ENSG00000242574
HLA-DOA GeneProduct ensembl:ENSG00000204252
HLA-DOB GeneProduct ensembl:ENSG00000241106
HLA-DPA1 GeneProduct ensembl:ENSG00000231389
HLA-E GeneProduct ensembl:ENSG00000204592
HLA-F GeneProduct ensembl:ENSG00000204642
HLA-G GeneProduct ensembl:ENSG00000204632
HLA-DPB1 GeneProduct ensembl:ENSG00000223865
HLA-DQA1 GeneProduct ensembl:ENSG00000196735
HLA-DQA2 GeneProduct ensembl:ENSG00000237541
HLA-DQB1 GeneProduct ensembl:ENSG00000179344
HLA-DQB2 GeneProduct ensembl:ENSG00000232629
HLA-DRA GeneProduct ensembl:ENSG00000204287
HLA-DRB1 GeneProduct ensembl:ENSG00000196126
HLA-DRB3 GeneProduct ncbigene:3125
HLA-DRB4 GeneProduct ncbigene:3126
HLA-DRB5 GeneProduct ensembl:ENSG00000198502
RELB GeneProduct ensembl:ENSG00000104856
Filamin B GeneProduct ncbigene:2317
Filamin C GeneProduct ncbigene:2318

References

  1. Developmental control of endocytosis in dendritic cells by Cdc42. Garrett WS, Chen LM, Kroschewski R, Ebersold M, Turley S, Trombetta S, et al. Cell. 2000 Aug 4;102(3):325–34. PubMed Europe PMC Scholia
  2. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Geijtenbeek TB, Krooshoop DJ, Bleijs DA, van Vliet SJ, van Duijnhoven GC, Grabovsky V, et al. Nat Immunol. 2000 Oct;1(4):353–7. PubMed Europe PMC Scholia
  3. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Chan SY, Empig CJ, Welte FJ, Speck RF, Schmaljohn A, Kreisberg JF, et al. Cell. 2001 Jul 13;106(1):117–26. PubMed Europe PMC Scholia
  4. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Panchal RG, Ruthel G, Kenny TA, Kallstrom GH, Lane D, Badie SS, et al. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15936–41. PubMed Europe PMC Scholia
  5. Ectodomain shedding of the glycoprotein GP of Ebola virus. Dolnik O, Volchkova V, Garten W, Carbonnelle C, Becker S, Kahnt J, et al. EMBO J. 2004 May 19;23(10):2175–84. PubMed Europe PMC Scholia
  6. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Gramberg T, Hofmann H, Möller P, Lalor PF, Marzi A, Geier M, et al. Virology. 2005 Sep 30;340(2):224–36. PubMed Europe PMC Scholia
  7. Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus. Murray JL, Mavrakis M, McDonald NJ, Yilla M, Sheng J, Bellini WJ, et al. J Virol. 2005 Sep;79(18):11742–51. PubMed Europe PMC Scholia
  8. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. Reid SP, Leung LW, Hartman AL, Martinez O, Shaw ML, Carbonnelle C, et al. J Virol. 2006 Jun;80(11):5156–67. PubMed Europe PMC Scholia
  9. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, et al. J Virol. 2006 Oct;80(20):10109–16. PubMed Europe PMC Scholia
  10. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. Feng Z, Cerveny M, Yan Z, He B. J Virol. 2007 Jan;81(1):182–92. PubMed Europe PMC Scholia
  11. The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells. Dominguez-Soto A, Aragoneses-Fenoll L, Martin-Gayo E, Martinez-Prats L, Colmenares M, Naranjo-Gomez M, et al. Blood. 2007 Jun 15;109(12):5337–45. PubMed Europe PMC Scholia
  12. New insights about host response to smallpox using microarray data. Esteves GH, Simoes ACQ, Souza E, Dias RA, Ospina R, Venancio TM. BMC Syst Biol. 2007 Aug 24;1:38. PubMed Europe PMC Scholia
  13. Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. Saeed MF, Kolokoltsov AA, Freiberg AN, Holbrook MR, Davey RA. PLoS Pathog. 2008 Aug 29;4(8):e1000141. PubMed Europe PMC Scholia
  14. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. Prins KC, Cárdenas WB, Basler CF. J Virol. 2009 Apr;83(7):3069–77. PubMed Europe PMC Scholia
  15. Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. Quinn K, Brindley MA, Weller ML, Kaludov N, Kondratowicz A, Hunt CL, et al. J Virol. 2009 Oct;83(19):10176–86. PubMed Europe PMC Scholia
  16. Evasion of interferon responses by Ebola and Marburg viruses. Basler CF, Amarasinghe GK. J Interferon Cytokine Res. 2009 Sep;29(9):511–20. PubMed Europe PMC Scholia
  17. Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions. Bhattacharyya S, Hope TJ, Young JAT. Virology. 2011 Oct 10;419(1):1–9. PubMed Europe PMC Scholia
  18. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, et al. Nature. 2011 Aug 24;477(7364):340–3. PubMed Europe PMC Scholia
  19. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. Brecher M, Schornberg KL, Delos SE, Fusco ML, Saphire EO, White JM. J Virol. 2012 Jan;86(1):364–72. PubMed Europe PMC Scholia
  20. The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold. Zhang APP, Bornholdt ZA, Liu T, Abelson DM, Lee DE, Li S, et al. PLoS Pathog. 2012 Feb;8(2):e1002550. PubMed Europe PMC Scholia
  21. Endocytic pathways involved in filovirus entry: advances, implications and future directions. Bhattacharyya S, Mulherkar N, Chandran K. Viruses. 2012 Dec;4(12):3647–64. PubMed Europe PMC Scholia
  22. TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine. Jemielity S, Wang JJ, Chan YK, Ahmed AA, Li W, Monahan S, et al. PLoS Pathog. 2013 Mar;9(3):e1003232. PubMed Europe PMC Scholia
  23. Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors. Brudner M, Karpel M, Lear C, Chen L, Yantosca LM, Scully C, et al. PLoS One. 2013;8(4):e60838. PubMed Europe PMC Scholia
  24. Host IQGAP1 and Ebola virus VP40 interactions facilitate virus-like particle egress. Lu J, Qu Y, Liu Y, Jambusaria R, Han Z, Ruthel G, et al. J Virol. 2013 Jul;87(13):7777–80. PubMed Europe PMC Scholia
  25. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, et al. Cell Host Microbe. 2013 Jul 17;14(1):74–84. PubMed Europe PMC Scholia
  26. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. Lennemann NJ, Rhein BA, Ndungo E, Chandran K, Qiu X, Maury W. mBio. 2014 Jan 28;5(1):e00862-13. PubMed Europe PMC Scholia
  27. Role of phosphatidylserine receptors in enveloped virus infection. Morizono K, Chen ISY. J Virol. 2014 Apr;88(8):4275–90. PubMed Europe PMC Scholia
  28. TIM-family proteins inhibit HIV-1 release. Li M, Ablan SD, Miao C, Zheng YM, Fuller MS, Rennert PD, et al. Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):E3699-707. PubMed Europe PMC Scholia
  29. Immune evasion in ebolavirus infections. Audet J, Kobinger GP. Viral Immunol. 2015 Feb;28(1):10–8. PubMed Europe PMC Scholia
  30. Ebola virus infection induces irregular dendritic cell gene expression. Melanson VR, Kalina WV, Williams P. Viral Immunol. 2015 Feb;28(1):42–50. PubMed Europe PMC Scholia
  31. Human lectins and their roles in viral infections. Mason CP, Tarr AW. Molecules. 2015 Jan 29;20(2):2229–71. PubMed Europe PMC Scholia
  32. Ebola virus VP35 interaction with dynein LC8 regulates viral RNA synthesis. Luthra P, Jordan DS, Leung DW, Amarasinghe GK, Basler CF. J Virol. 2015 May;89(9):5148–53. PubMed Europe PMC Scholia
  33. Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection. Okumura A, Rasmussen AL, Halfmann P, Feldmann F, Yoshimura A, Feldmann H, et al. J Virol. 2015 Oct;89(20):10399–406. PubMed Europe PMC Scholia
  34. Targeting C-Type Lectin Receptors for Cancer Immunity. Yan H, Kamiya T, Suabjakyong P, Tsuji NM. Front Immunol. 2015 Aug 24;6:408. PubMed Europe PMC Scholia
  35. Ebolavirus Glycoprotein Directs Fusion through NPC1+ Endolysosomes. Simmons JA, D’Souza RS, Ruas M, Galione A, Casanova JE, White JM. J Virol. 2015 Oct 14;90(1):605–10. PubMed Europe PMC Scholia
  36. TIM-1 acts a dual-attachment receptor for Ebolavirus by interacting directly with viral GP and the PS on the viral envelope. Yuan S, Cao L, Ling H, Dang M, Sun Y, Zhang X, et al. Protein Cell. 2015 Nov;6(11):814–24. PubMed Europe PMC Scholia
  37. Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism. Vande Burgt NH, Kaletsky RL, Bates P. Viruses. 2015 Oct 26;7(10):5587–602. PubMed Europe PMC Scholia
  38. Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1. Wang H, Shi Y, Song J, Qi J, Lu G, Yan J, et al. Cell. 2016 Jan 14;164(1–2):258–68. PubMed Europe PMC Scholia
  39. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway. Spence JS, Krause TB, Mittler E, Jangra RK, Chandran K. mBio. 2016 Feb 9;7(1):e01857-15. PubMed Europe PMC Scholia